1. Home
  2. GKOS vs AMKR Comparison

GKOS vs AMKR Comparison

Compare GKOS & AMKR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Glaukos Corporation

GKOS

Glaukos Corporation

N/A

Current Price

$238.12

Market Cap

9.7B

Sector

Health Care

ML Signal

N/A

Logo Amkor Technology Inc.

AMKR

Amkor Technology Inc.

N/A

Current Price

$34.15

Market Cap

8.5B

Sector

Technology

ML Signal

N/A

Company Overview

Basic Information
Metric
GKOS
AMKR
Founded
1998
1968
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Semiconductors
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
9.7B
8.5B
IPO Year
2015
1997

Fundamental Metrics

Financial Performance
Metric
GKOS
AMKR
Price
$238.12
$34.15
Analyst Decision
Strong Buy
Buy
Analyst Count
13
11
Target Price
★ $243.85
$65.70
AVG Volume (30 Days)
1.5M
★ 4.9M
Earning Date
10-28-2026
10-26-2026
Dividend Yield
N/A
★ 0.95%
EPS Growth
N/A
★ 4.90
EPS
N/A
★ 1.79
Revenue
$507,442,000.00
★ $4,052,650,000.00
Revenue This Year
$53.82
$12.23
Revenue Next Year
$28.56
$14.14
P/E Ratio
★ N/A
$19.29
Revenue Growth
★ 32.33
N/A
52 Week Low
$93.78
$30.03
52 Week High
$255.19
$96.68

Technical Indicators

Market Signals
Indicator
GKOS
AMKR
Relative Strength Index (RSI) 59.90 40.08
Support Level $147.72 $30.73
Resistance Level $255.19 $51.89
Average True Range (ATR) 11.84 2.34
MACD -1.49 0.34
Stochastic Oscillator 43.31 39.91

Price Performance

Historical Comparison
GKOS
AMKR

About GKOS Glaukos Corporation

Glaukos Corp is an ophthalmic pharmaceutical and medical technology company focused on developing novel, dropless therapies and commercializing associated products for the treatment of glaucoma, corneal disorders, and retinal diseases. It has commenced commercialization activities for iDose TR, a first-of-its-kind, long-duration, intracameral procedural pharmaceutical implant designed to continuously deliver glaucoma drug therapy inside the eye for extended periods of time. The company also offer commercially a proprietary bio-activated pharmaceutical therapy for the treatment of a rare corneal disorder, keratoconus. The company has three primary commercialized micro-scale surgical device products designed to treat glaucoma: the iStent, the iStent inject W, and the iStent infinite.

About AMKR Amkor Technology Inc.

Amkor Technology Inc is a OSAT (outsourced semiconductor assembly and test) service provider. It has pioneered the outsourcing of integrated circuit (IC) packaging and test services and is a strategic manufacturing partner for the semiconductor companies, foundries, and electronics original equipment manufacturers (OEMs). The firm's products are organized into two categories namely advanced products that include flip chip, fine pitch bumping, wafer-level processing, advanced SiPs, power modules, and others, and Mainstream products that includes wirebond packaging and testing. The company derives maximum revenue from the advanced products category. The company derives majority of its revenue from Foreign states.

Share on Social Networks: